Reuters logo
8 months ago
BRIEF-Catalyst Pharmaceuticals updates on trial for patients with congenital myasthenic syndromes
December 8, 2016 / 1:44 PM / 8 months ago

BRIEF-Catalyst Pharmaceuticals updates on trial for patients with congenital myasthenic syndromes

Dec 8 (Reuters) - Catalyst Pharmaceuticals Inc

* Allowing Adult CMS patients to participate in trial

* "Continue to believe that we will report top-line results from this study in second half of 2017"

* Number of patients increased to approximately 20

* Provides update on its clinical trial for patients with congenital myasthenic syndromes Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below